Cargando…
NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis
Endogenous glutamate (Glu) release and N-methyl-d-aspartate (NMDA) receptor (NMDAR) activation are associated with lung injury in different animal models. However, the underlying mechanism is unclear. Bone marrow-derived mesenchymal stem cells (BM-MSCs), which show potential use for immunomodulation...
Autores principales: | Li, Xiaohong, Li, Chen, Tang, Yiting, Huang, Yanhong, Cheng, Qingmei, Huang, Xiaoting, Zhao, Feiyan, Hao, Caixia, Feng, Dandan, Xu, Jianping, Han, Jianzhong, Tang, Siyuan, Liu, Wei, Yue, Shaojie, Luo, Ziqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Physiological Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172623/ https://www.ncbi.nlm.nih.gov/pubmed/29722562 http://dx.doi.org/10.1152/ajplung.00002.2018 |
Ejemplares similares
-
NMDA receptor activation inhibits the protective effect of BM-MSCs on bleomycin-induced lung epithelial cell damage by inhibiting ERK signaling and the paracrine factor HGF
por: Peng, Xiangping, et al.
Publicado: (2019) -
Pretreatment with G-CSF Could Enhance the Antifibrotic Effect of BM-MSCs on Pulmonary Fibrosis
por: Zhao, Feiyan, et al.
Publicado: (2019) -
NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury
por: Li, Yang, et al.
Publicado: (2015) -
Megakaryocytes participate in the occurrence of bleomycin-induced pulmonary fibrosis
por: Zhou, Yan, et al.
Publicado: (2019) -
Anti-Inflammatory, Antioxidant, and Antifibrotic Effects of Gingival-Derived MSCs on Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Wang, Xishuai, et al.
Publicado: (2021)